Walgreens Boots Alliance said on Tuesday it named Roz Brewer, the outgoing chief operating officer of Starbucks, as the company's chief executive officer.
路透新闻部
(Adds details, background)
KUALA LUMPUR, Jan 26 (Reuters) - Malaysia said on Tuesday it had signed deals with two domestic companies to purchase 18.4 million doses of COVID-19 vaccines produced by Russia’s Gamaleya Research Institute and China’s Sinovac.
Malaysian pharmaceutical firm Duopharma will supply the government with 6.4 million doses of Gamaleya’s Sputnik V vaccine in stages from March, the health ministry said in a statement.
Malaysia Pharmaniaga Berhad will supply 12 million doses of Sinovac’s vaccine from April, the ministry said.
The deals will ensure enough supplies to cover 9.2 million people, or 28.75% of the population, subject to approval by Malaysia’s pharmaceutical regulators, it added.
Represents 33% premium to 1-month average price - sources Consortium seeks to finalize deal by end-March - sources 2020 HK-listed take-private deals rose to $25 bln - Refinitiv
HONG KONG, Jan 27 (Reuters) - A consortium led by state-owned pharma giant Sinopharm plans to take private China Traditional Chinese Medicine Holdings in a deal that would value the firm at at least $3.3 billion, said two people with direct knowledge of the matter.
Sinopharm, China TCM’s parent and major shareholder, is teaming up with the next two biggest stockholders, Ping An Insurance Group Co of China and executive director Wang Xiaochun, said the people, with the three holding a combined 49.4% stake.
Brazil's President Jair Bolsonaro, a longtime China skeptic, thanked Beijing on Monday for rapidly approving the export of active ingredients for local COVID-19 vaccine production, as his government scrambles to secure scarce shots.
9 Min Read
Jan 25 (Reuters) - When Randall Stephenson joined 180 of his peers leading many of the richest U.S. companies in signing the Business Roundtable pledge on the “purpose of a corporation” in August 2019, the then-chief of AT&T Inc promised to look out for the interests of all the wireless carrier’s stakeholders, not just shareholders.
Two months later, the Dallas-based company outlined a plan for cost reductions that also prioritized dividends and stock buybacks for shareholders, succumbing to pressure from $41 billion hedge fund Elliott Investment Management LP.
Activist investor Elliott had said its proposals would deliver “substantial benefits” for shareholders, consumers and employees, but not everybody came out ahead.